Published in Parasitol Res on June 27, 2015
Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med (2009) 33.25
A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature (2013) 11.03
Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet (2004) 9.68
Antimalarial drug resistance. J Clin Invest (2004) 8.50
Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6. Lancet (2005) 8.30
Artemisinins target the SERCA of Plasmodium falciparum. Nature (2003) 7.72
Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies. Lancet Infect Dis (2013) 6.06
The parasite clearance curve. Malar J (2011) 4.30
Resistance to antimalarials in Southeast Asia and genetic polymorphisms in pfmdr1. Antimicrob Agents Chemother (2003) 4.01
A single amino acid residue can determine the sensitivity of SERCAs to artemisinins. Nat Struct Mol Biol (2005) 3.18
Genetic architecture of artemisinin-resistant Plasmodium falciparum. Nat Genet (2015) 3.03
Delaying antimalarial drug resistance with combination chemotherapy. Parassitologia (1999) 3.00
Antidogmatic approaches to artemisinin resistance: reappraisal as treatment failure with artemisinin combination therapy. Trends Parasitol (2013) 2.76
The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa. Trop Med Int Health (2007) 2.17
Artemisinins and the biological basis for the PfATP6/SERCA hypothesis. Trends Parasitol (2010) 1.98
Artemisinin resistance is a clear and present danger. Trends Parasitol (2013) 1.62
Measuring the efficacy of anti-malarial drugs in vivo: quantitative PCR measurement of parasite clearance. Malar J (2010) 1.50
In vitro monitoring of Plasmodium falciparum drug resistance in French Guiana: a synopsis of continuous assessment from 1994 to 2005. Antimicrob Agents Chemother (2007) 1.49
Molecular monitoring of Plasmodium falciparum resistance to artemisinin in Tanzania. Malar J (2006) 1.48
A single-step, PCR-based method for the detection and differentiation of Plasmodium vivax and P. falciparum. Ann Trop Med Parasitol (2003) 1.46
Applied genomics: data mining reveals species-specific malaria diagnostic targets more sensitive than 18S rRNA. J Clin Microbiol (2011) 1.32
No PfATPase6 S769N mutation found in Plasmodium falciparum isolates from China. Malar J (2008) 1.31
Plasmodium falciparum from Pará state (Brazil) shows satisfactory in vitro response to artemisinin derivatives and absence of the S769N mutation in the SERCA-type PfATPase6. Trop Med Int Health (2008) 1.22
Monitoring for multidrug-resistant Plasmodium falciparum isolates and analysis of pyrimethamine resistance evolution in Uige province, Angola. Trop Med Int Health (2009) 1.19
Monitoring antimalarial drug resistance in India via sentinel sites: outcomes and risk factors for treatment failure, 2009-2010. Bull World Health Organ (2012) 1.17
Geographic structuring of the Plasmodium falciparum sarco(endo)plasmic reticulum Ca2+ ATPase (PfSERCA) gene diversity. PLoS One (2010) 1.17
Perspective: artemisinin-resistant malaria and the wolf. Am J Trop Med Hyg (2012) 1.11
Molecular epidemiology of malaria in Cameroon. XXVIII. In vitro activity of dihydroartemisinin against clinical isolates of Plasmodium falciparum and sequence analysis of the P. falciparum ATPase 6 gene. Am J Trop Med Hyg (2009) 1.09
Molecular analysis of pfatp6 and pfmdr1 polymorphisms and their association with in vitro sensitivity in Plasmodium falciparum isolates from the Thai-Myanmar border. Acta Trop (2011) 1.09
Plasmodium sensitivity to artemisinins: magic bullets hit elusive targets. Trends Parasitol (2010) 1.06
Artemether resistance in vitro is linked to mutations in PfATP6 that also interact with mutations in PfMDR1 in travellers returning with Plasmodium falciparum infections. Malar J (2012) 1.03
Declining efficacy of artesunate plus sulphadoxine-pyrimethamine in northeastern India. Malar J (2014) 1.02
Lack of association of the S769N mutation in Plasmodium falciparum SERCA (PfATP6) with resistance to artemisinins. Antimicrob Agents Chemother (2012) 1.01
Spontaneous mutations in the Plasmodium falciparum sarcoplasmic/ endoplasmic reticulum Ca2+-ATPase (PfATP6) gene among geographically widespread parasite populations unexposed to artemisinin-based combination therapies. Antimicrob Agents Chemother (2010) 1.01
Status of potential PfATP6 molecular markers for artemisinin resistance in Suriname. Malar J (2012) 1.00
Comparative efficacies of artemisinin combination therapies in Plasmodium falciparum malaria and polymorphism of pfATPase6, pfcrt, pfdhfr, and pfdhps genes in tea gardens of Jalpaiguri District, India. Antimicrob Agents Chemother (2012) 0.96
Drug resistance genomics of the antimalarial drug artemisinin. Genome Biol (2014) 0.95
Biological actions of artemisinin: insights from medicinal chemistry studies. Molecules (2010) 0.94
Counter perspective: artemisinin resistance: facts, fears, and fables. Am J Trop Med Hyg (2012) 0.88
Plasmodium falciparum isolates from southern Ghana exhibit polymorphisms in the SERCA-type PfATPase6 though sensitive to artesunate in vitro. Malar J (2011) 0.88
Artemisinin derivatives for treatment of uncomplicated Plasmodium falciparum malaria in Sudan: too early for too much hope. Parasitol Res (2009) 0.82
Molecular monitoring of antimalarial drug resistance among Plasmodium falciparum field isolates from Odisha, India. Acta Trop (2013) 0.81
A clinical and molecular study of artesunate + sulphadoxine-pyrimethamine in three districts of central and eastern India. Malar J (2013) 0.80
Therapeutic efficacy of artemisinin combination therapies and prevalence of S769N mutation in PfATPase6 gene of Plasmodium falciparum in Kolkata, India. Asian Pac J Trop Med (2013) 0.77
Pfatp6 molecular profile of Plasmodium falciparum isolates in the western Brazilian Amazon. Malar J (2012) 0.76
Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med (2014) 11.87
Burden of malaria in India: retrospective and prospective view. Am J Trop Med Hyg (2007) 3.75
Antimalarial drug resistance of Plasmodium falciparum in India: changes over time and space. Lancet Infect Dis (2011) 2.47
The malaria parasite Plasmodium vivax exhibits greater genetic diversity than Plasmodium falciparum. Nat Genet (2012) 2.43
Malaria in India: challenges and opportunities. J Biosci (2008) 2.40
Plasmodium falciparum isolates in India exhibit a progressive increase in mutations associated with sulfadoxine-pyrimethamine resistance. Antimicrob Agents Chemother (2004) 2.04
Dissecting virulence pathways of Mycobacterium tuberculosis through protein-protein association. Proc Natl Acad Sci U S A (2006) 1.95
Ultrasonographic evaluation of the omasum in cows and buffaloes. Vet Radiol Ultrasound (2008) 1.62
Pyronaridine-artesunate versus chloroquine in patients with acute Plasmodium vivax malaria: a randomized, double-blind, non-inferiority trial. PLoS One (2011) 1.54
A multicenter study of azithromycin, alone and in combination with chloroquine, for the treatment of acute uncomplicated Plasmodium falciparum malaria in India. J Infect Dis (2005) 1.49
An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia. PLoS One (2010) 1.48
Progressive increase in point mutations associated with chloroquine resistance in Plasmodium falciparum isolates from India. J Infect Dis (2006) 1.45
Malaria in India: the center for the study of complex malaria in India. Acta Trop (2011) 1.42
Why is it important to study malaria epidemiology in India? Trends Parasitol (2009) 1.42
Prevalence and outcome of hepatobiliary dysfunction in neonatal septicaemia. J Pediatr Gastroenterol Nutr (2012) 1.42
Pyronaridine-artesunate versus mefloquine plus artesunate for malaria. N Engl J Med (2012) 1.36
Genetic deletion of HRP2 and HRP3 in Indian Plasmodium falciparum population and false negative malaria rapid diagnostic test. Acta Trop (2012) 1.35
Prevalence of the K76T mutation in the pfcrt gene of Plasmodium falciparum among chloroquine responders in India. Acta Trop (2003) 1.31
Therapeutic efficacy of chloroquine in Plasmodium vivax from areas with different epidemiological patterns in India and their Pvdhfr gene mutation pattern. Trans R Soc Trop Med Hyg (2006) 1.30
Histopathology of fatal respiratory distress caused by Plasmodium vivax malaria. Am J Trop Med Hyg (2009) 1.27
Arterolane, a new synthetic trioxolane for treatment of uncomplicated Plasmodium falciparum malaria: a phase II, multicenter, randomized, dose-finding clinical trial. Clin Infect Dis (2010) 1.27
Probiotics, their health benefits and applications for developing healthier foods: a review. FEMS Microbiol Lett (2012) 1.24
Low efficacy of chloroquine: time to switchover to artemisinin-based combination therapy for falciparum malaria in India. Acta Trop (2009) 1.23
Malaria in South Asia: prevalence and control. Acta Trop (2012) 1.23
Genetic structure of Plasmodium falciparum field isolates in eastern and north-eastern India. Malar J (2007) 1.20
Monitoring antimalarial drug resistance in India via sentinel sites: outcomes and risk factors for treatment failure, 2009-2010. Bull World Health Organ (2012) 1.17
Malaria-attributed death rates in India. Lancet (2011) 1.16
Traditional uses of medicinal plants among the rural communities of Churu district in the Thar Desert, India. J Ethnopharmacol (2007) 1.16
A proteogenomic analysis of Anopheles gambiae using high-resolution Fourier transform mass spectrometry. Genome Res (2011) 1.14
A phase III, randomized, non-inferiority trial to assess the efficacy and safety of dihydroartemisinin-piperaquine in comparison with artesunate-mefloquine in patients with uncomplicated Plasmodium falciparum malaria in southern Laos. Am J Trop Med Hyg (2010) 1.14
The lin genes for γ-hexachlorocyclohexane degradation in Sphingomonas sp. MM-1 proved to be dispersed across multiple plasmids. Biosci Biotechnol Biochem (2011) 1.13
Similar trends of pyrimethamine resistance-associated mutations in Plasmodium vivax and P. falciparum. Antimicrob Agents Chemother (2006) 1.12
Malarial morbidity in tribal communities living in the forest and plain ecotypes of Orissa, India. Ann Trop Med Parasitol (2004) 1.11
Field evaluation of ZeroFly--an insecticide incorporated plastic sheeting against malaria vectors & its impact on malaria transmission in tribal area of northern Orissa. Indian J Med Res (2009) 1.10
Arterolane maleate plus piperaquine phosphate for treatment of uncomplicated Plasmodium falciparum malaria: a comparative, multicenter, randomized clinical trial. Clin Infect Dis (2012) 1.10
Metabolic engineering of Escherichia coli: a sustainable industrial platform for bio-based chemical production. Biotechnol Adv (2013) 1.09
Genetic variation in histidine rich proteins among Indian Plasmodium falciparum population: possible cause of variable sensitivity of malaria rapid diagnostic tests. Malar J (2012) 1.09
Enhanced biodegradation of beta- and delta-hexachlorocyclohexane in the presence of alpha- and gamma-isomers in contaminated soils. Environ Sci Technol (2005) 1.09
A double-blind, randomized study of azithromycin compared to chloroquine for the treatment of Plasmodium vivax malaria in India. Am J Trop Med Hyg (2005) 1.05
Role of transgenic plants in agriculture and biopharming. Biotechnol Adv (2011) 1.05
Clinico-epidemiological profile and high-level aminoglycoside resistance in enterococcal septicemia from a tertiary care hospital in east Delhi. Int J Appl Basic Med Res (2011) 1.04
Selective loss of lin genes from hexachlorocyclohexane-degrading Pseudomonas aeruginosa ITRC-5 under different growth conditions. Appl Microbiol Biotechnol (2007) 1.04
Declining efficacy of artesunate plus sulphadoxine-pyrimethamine in northeastern India. Malar J (2014) 1.02
Do comorbid psychiatric disorders contribute to the pathogenesis of tako-tsubo syndrome? A review of pathogenesis. Congest Heart Fail (2009) 1.02
Pattern of Candida isolates in hospitalized children. Indian J Pediatr (2008) 1.01
Ethnomedicinal and ethnopharmaco-statistical studies of Eastern Rajasthan, India. J Ethnopharmacol (2010) 1.00
Mosquito biting activity on humans & detection of Plasmodium falciparum infection in Anopheles stephensi in Goa, India. Indian J Med Res (2012) 1.00
Evaluation of the antimicrobial, antioxidant, and anti-inflammatory activities of hydroxychavicol for its potential use as an oral care agent. Antimicrob Agents Chemother (2008) 1.00
Operational feasibility of rapid diagnostic kits & blister packs use for malaria control in high transmission areas of Orissa & Chhattisgarh. Indian J Med Res (2007) 0.99
The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data. BMC Med (2015) 0.99
Piperine, a phytochemical potentiator of ciprofloxacin against Staphylococcus aureus. Antimicrob Agents Chemother (2006) 0.98
Malaria-attributed death rates in India. Lancet (2011) 0.97
Redox biology of tuberculosis pathogenesis. Adv Microb Physiol (2012) 0.96
Piperine as an inhibitor of the MdeA efflux pump of Staphylococcus aureus. J Med Microbiol (2011) 0.95
In vitro assessment of drug resistance in Plasmodium falciparum in five States of India. Indian J Med Res (2012) 0.95
The mechanism of redox sensing in Mycobacterium tuberculosis. Free Radic Biol Med (2012) 0.95
Therapeutic efficacy and safety of dihydroartemisinin-piperaquine versus artesunate-mefloquine in uncomplicated Plasmodium falciparum malaria in India. Malar J (2012) 0.95
Bipartite clavicular attachment of the sternocleidomastoid muscle: a case report. Anat Cell Biol (2012) 0.94
Plasmodium vivax merozoite surface protein-3 alpha: a high-resolution marker for genetic diversity studies. J Vector Borne Dis (2010) 0.94
Piperine analogs as potent Staphylococcus aureus NorA efflux pump inhibitors. Bioorg Med Chem (2008) 0.93
Sequence diversity and natural selection at domain I of the apical membrane antigen 1 among Indian Plasmodium falciparum populations. Malar J (2007) 0.93
Bioactive peptides derived from milk proteins and their health beneficial potentials: an update. Food Funct (2010) 0.92
Degradation of beta-Hexachlorocyclohexane by Haloalkane Dehalogenase LinB from Sphingomonas paucimobilis UT26. Appl Environ Microbiol (2005) 0.92
Antimalarial drug policy in India: past, present & future. Indian J Med Res (2014) 0.91
Malaria evolution in South Asia: knowledge for control and elimination. Acta Trop (2012) 0.91
Citral derived amides as potent bacterial NorA efflux pump inhibitors. Bioorg Med Chem (2008) 0.90
Wash resistance and bioefficacy of Olyset net--a long-lasting insecticide-treated mosquito net against malaria vectors and nontarget household pests. J Med Entomol (2006) 0.89
Prescription practices and availability of artemisinin monotherapy in India: where do we stand? Malar J (2011) 0.89
Human IL10 gene repression by Rev-erbα ameliorates Mycobacterium tuberculosis clearance. J Biol Chem (2013) 0.88
Resting behavior and malaria vector incrimination of Anopheles stephensi in Goa, India. J Am Mosq Control Assoc (2004) 0.88
Chloroquine efficacy studies confirm drug susceptibility of Plasmodium vivax in Chennai, India. Malar J (2014) 0.88
Retrospective study of chikungunya outbreak in urban areas of India. Indian J Med Res (2012) 0.88
Inhibition of adipogenesis and induction of apoptosis and lipolysis by stem bromelain in 3T3-L1 adipocytes. PLoS One (2012) 0.88
Valsartan-induced angioedema. Ann Pharmacother (2003) 0.88
Microsomal epoxide hydrolase (EPHX1), slow (exon 3, 113His) and fast (exon 4, 139Arg) alleles confer susceptibility to squamous cell esophageal cancer. Toxicol Appl Pharmacol (2008) 0.87
Environmental heme-based sensor proteins: implications for understanding bacterial pathogenesis. Antioxid Redox Signal (2012) 0.87
Rapid detection of Plasmodium vivax in saliva and blood using loop mediated isothermal amplification (LAMP) assay. J Infect (2013) 0.87